Hepatitis B vaccine - Shanghai Fudan Haitai BiotechnologyAlternative Names: HBsAg-HBIG complex; Hepatitis B immune globulin-hepatitis B vaccine recombinant complex; Hepatitis B vaccine/hepatitis B immune globulin; Yeast-derived immunogenic complex; YIC
Latest Information Update: 26 Nov 2015
At a glance
- Originator Fudan University
- Developer Fudan University; Shanghai Haitai Pharmaceutical Biotechnology
- Class Hepatitis B vaccines; Immunoglobulins; Synthetic vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase III Hepatitis B